UK regulator halts sales of Tavneos; UniQure seeks approval for Huntington's gene therapy

Plus, news about Regeneron, Novocure, Jazz's Ziihera, BioMarin, Ascendis, AstraZeneca, Hutchmed and TScan Therapeutics. Another road bump for Tavneos: The Medicines and Healthcare products Regulatory Agency (MHRA) has followed the EMA’s lead ...